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Summary
Objective: Excess reactive oxygen species and oxidative damage have been associated with the pathogenesis of osteoarthritis (OA). Extra-
cellular superoxide dismutase (EC-SOD or SOD3) scavenges superoxide is the major catalytic antioxidant in joint ﬂuid and is decreased in OA
cartilage. We studied human joint ﬂuid samples to test whether there is an association between OA and EC-SOD or other low molecular
antioxidants in the joint ﬂuid.
Methods: Joint ﬂuid samples were obtained from 28 subjects with severe OA undergoing arthrocentesis or knee joint replacement and com-
pared to joint ﬂuid from 12 subjects undergoing knee arthroscopy for chronic knee pain, meniscal tears or anterior cruciate ligament recon-
struction. EC-SOD protein was assayed by enzyme-linked immunosorbent assay (ELISA). Ascorbate and urate were measured with high
performance liquid chromatography (HPLC) and total nitrates by the Greiss reaction. Glutathione (GSH) and oxidized glutathione were mea-
sured using a colorimetric method. Interleukin-6 (IL-6) and transforming growth factor-beta (TGF-beta) were both measured with ELISA.
Results: Human joint ﬂuid contains signiﬁcant amounts of the extracellular, catalytic antioxidant EC-SOD. Joint ﬂuid from OA subjects is char-
acterized by signiﬁcantly decreased EC-SOD levels and signiﬁcant decreases in GSH, and ascorbate compared to the reference group of
knee joints with pain or subacute injury but macroscopically intact cartilage. GSH and ascorbate show only an age effect with no effect
from disease state on regression modeling. Urate is present in joint ﬂuid but does not show a signiﬁcant difference between groups. IL-6
and TGF-beta both show non-signiﬁcant trends to increases in the arthritic subjects. There was no correlation of EC-SOD levels with IL-6
as a marker of inﬂammation in either the comparison group or the OA group.
Conclusions: EC-SOD, the major scavenger of reactive oxygen species (ROS) in extracellular spaces and ﬂuids, is decreased in late stage
OA joint ﬂuid compared to ﬂuid from injured/painful joints with intact cartilage. Injured joints may be able to increase or maintain secretion of
EC-SOD but it appears that late stage OA joints fail to do so in spite of increased oxidative stress seen in the disease. Associated age related
declines in GSH and ascorbate might also contribute to the development of severe OA. The net effect of these changes in joint ﬂuid antiox-
idants is likely to accelerate the damaging oxidant effects on extracellular matrix stability in cartilage tissue.
ª 2007 Osteoarthritis Research Society International. Published by Elsevier Ltd. All rights reserved.
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Glutathione, Urate, Ascorbate, Redox, TGF-beta, IL-6.Osteoarthritis (OA) is a disabling disease of the joints that
affects up to half of the aging population, but has neither
a clear etiology nor an effective treatment1. It causes stiff-
ness, pain, and deformity, most often in the major weight-
bearing joints and results in a focal, progressive loss of
articular cartilage with formation of bony osteophytes
around the joint margins. Advancing age, genetic factors
and mechanical damage all play a role in OA2. There are
no diagnostic tests to conﬁrm the disease, and radiographic
evidence often occurs late, after signiﬁcant loss of cartilage
tissue. Although OA is thought to be a disease of articular
cartilage, it has effects throughout the joint, including the
formation of marginal osteophytes, increased subchondral
bone stiffness, variable degrees of synovial hypertrophy
and decreased joint ﬂuid viscosity.*Address correspondence and reprint requests to: Dr Elizabeth
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515We have recently shown that the primary, catalytic antiox-
idant of the extracellular spaces, extracellular superoxide
dismutase (EC-SOD or SOD3) is present in articular carti-
lage and profoundly decreased in human OA cartilage3.
Furthermore, we found transient decreases in EC-SOD in
pre-lesional cartilage associated with progressive increases
in nitrotyrosine residues in a spontaneous animal model of
OA, the STR/ort mouse. Evidence has continued to accu-
mulate that OA is mediated in part by reactive oxygen
and nitrogen species4e6.
There are three distinct SODs found in the human body:
SOD1 or CuZn SOD which localizes primarily to the cytosol,
SOD2 or Mn SOD found in the mitochondria, and SOD3 or
EC-SOD. EC-SOD is a secreted, tetrameric, glycoprotein
with a positively charged heparin-binding site7. The active
center contains copper and zinc and is homologous with
SOD1, but the EC-SOD molecule is immunologically dis-
tinct from SOD1. It localizes to the surface of cells and
the extracellular matrix of tissues by binding to the nega-
tively charged molecules including proteoglycans and colla-
gen8,9. In this extracellular location it can protect the
vulnerable proteins and macromolecules of the extracellular
matrix from oxidant injury. McCord10 found that SOD could
protect joint ﬂuid hyaluronate from being oxidatively cleaved
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in joint ﬂuids and plasma ﬁnding that EC-SOD is three times
higher in joint ﬂuid compared with plasma and decreased in
rheumatoid arthritis (RA) joint ﬂuid. He did not study
EC-SOD in OA joint ﬂuid.
Joint ﬂuid is produced as a transudate of plasma from sy-
novial cells and provides nutrition to the articular cartilage
by diffusion of oxygen and other molecules. Changes in
the constituents of joint ﬂuid may reﬂect physiologic events
in the articular cartilage. We expected that OA joint ﬂuid
would show altered levels of EC-SOD and other antioxi-
dants in response to a state of oxidant stress within the
OA cartilage and joint. We chose to study speciﬁc non-
catalytic antioxidants [ascorbate, urate, oxidized glutathione
(GSSG) and reduced glutathione (GSH)] in addition to EC-
SOD. The GSH couple is known to be an intracellular anti-
oxidant, and chondrocytes stressed oxidatively had greater
incidence of cell death when they had been depleted of
GSH or had higher levels of the oxidized form of GSH12.
Ascorbate was chosen for the study because it is important
in collagen biosynthesis and has antioxidant effects. Urate
was also studied because it is a known constituent of joint
ﬂuid, and has the ability to act as a scavenger of reactive
oxygen species13,14.
We studied joint ﬂuid from patients with severe knee OA
at joint replacement or when patients were having arthro-
centesis performed for diagnostic or therapeutic purposes.
We compared these to joint ﬂuid from patients undergoing
knee arthroscopy for meniscal tears or knee pain in which
the articular cartilage was evaluated arthroscopically and
there was no evidence of OA. We looked to conﬁrm that
EC-SOD was present in joint ﬂuid and compared the levels
in OA joint ﬂuid to ﬂuid from joints with macroscopically in-
tact cartilage. We also looked at the pattern of selected non-
catalytic antioxidants in joint ﬂuid to see if there were other
compensatory changes in the antioxidants in OA joint ﬂuid.Materials and methodsHUMAN SYNOVIAL FLUIDJoint ﬂuid was collected from patients undergoing total knee replacement
or who were having arthrocentesis in association with either steroid injection
or hyaluronate injection for the group with advanced degenerative arthritis.
This group is described as OA patients (n¼ 27). The comparison group joint
ﬂuid was obtained from patients with normal knee radiographs who were
having their knee arthroscoped for a meniscal lesion, knee pain or anterior
cruciate ligament (ACL) reconstruction (controls, n¼ 12). Exclusion criteria
for both groups included a history of RA, local joint infection or gout. Joint
ﬂuid was aspirated from the joint with a 20 gage or larger needle before
the joint was inﬁltrated with local anesthesia during arthroscopy. Subjects
were excluded from the comparison group if at the time of arthroscopy, visual
inspection of the articular surfaces demonstrated lesions consistent with
OA e speciﬁcally areas of exposed bone and or extensive areas of chondro-
malacia (more than one compartment involved or more than 1 cm diameter
of chondromalacia). Subjects were included in the comparison group if
they demonstrated small (less than 1 cm diameter), partial thickness lesions
(grade 2 chondromalacia) in only one compartment of the knee during the
arthroscopic inspection of the joint. Written informed consent was obtained
from all human subjects and the protocol was reviewed and approved by
the Exempla Hospital IRB and National Jewish IRB. Height, weight, age
and gender information was recorded for each subject, and body mass index
(BMI) [BMI¼ (weight in kg)/height in m2] was calculated. Each joint ﬂuid sam-
ple was centrifuged at 3000 rpm to remove any cells and the supernatant
stored at 80C.Table I
Baseline characteristics of study subjectsEC-SOD ENZYME-LINKED IMMUNOSORBENT ASSAY (ELISA)
Number Mean age
(years)
BMI Male Female
Control group 12 37 27 6 6
OA group 28 64 33 11 17EC-SOD antibody #97-5 was a rabbit polyclonal antibody raised against
alkylated puriﬁed human EC-SOD. EC-SOD antibody #4G11G6 was
a mouse monoclonal antibody raised against human EC-SOD puriﬁed from
aortas. Protein concentrations were determined for the joint ﬂuids using
the BCA Protein Assay Kit (Pierce; Rockford, IL).EC-SOD protein was quantiﬁed using a sandwich ELISA. Ninety-six well
Maxisorb immunoplates (Nunc; Naperville, IL) were coated with capture anti-
body 4G11G6, Ms a hEC-SOD, at 1 mg/ml in 100 mM sodium phosphate, pH
8.4 at 4C overnight. The plate was washed with tris buffered saline with
Tween (TBS-T) (0.1% Tween-20) after all incubations. Wells were blocked
with 1% bovine serum albumin (BSA) (fraction V fatty acid free)/10% normal
goat serum/phosphate buffered saline (PBS) at 200 ml/well. Samples, includ-
ing cartilage lysates and rhEC-SOD standard (31 pg/mle2 ng/ml), were
diluted in 1% BSA (fraction V fatty acid free)/0.05% Tw-20. Detection antibody
97-5, Rb a hEC-SOD, was added at 1:10,000 in blocking solution. Secondary
antibody, Gt a Rb-biotin (ABC Elite Vectastain kit for Rb IgG; Vector Labs;
Burlingame, CA), was used at 1:200 in blocking solution. The avidin biotin
complex (ABC) solution was incubated for 15 min at 37C. ABTS (product
component of ABC kit) substrate solution was added at 100 ml/well.
Absorbance was measured at 405 nm. EC-SOD per mg of total protein was
calculated for all of the samples.HPLC DETERMINATIONS OF ASCORBATE AND URATEJoint ﬂuid samples were treated with 150 ml of 5% metaphosphoric acid
added to 350 ml of the ﬂuid supernatant after centrifugation to precipitate pro-
teins, and then incubated on ice for 10 min before repeat centrifugation and
separation of the protein depleted supernatant. This supernatant was ana-
lyzed for ascorbate and urate by high performance liquid chromatography
with electrochemical detection using an ESA Coularray (Chelmsford, MA).
Ascorbate and urate standards were obtained from Sigma (St Louis, MO).
Detection potentials were set at 100, 250, 600 and 670 mV. Five microliters
of sample was injected onto a 4.6 250 mm YMC ODS-AQ S5 mM 120 A˚
column (Waters, Milford, MA). Antioxidants were eluted with mobile phase
(potassium phosphate 125 mM, acetonitrile 1%, pH 3.0) at 0.75 mL/min.
GSH and GSSGwere measured using the Bioxytech GSH/GSSG-412 kit
(OxisResearch, Portland, OR) that is a colorimetric method for measuring
both reduced GSH and GSSG.TOTAL NITRATESNitrites and nitrates were measured using the Greiss reaction15 and sep-
arately analyzed as nitrites (NO2
), nitrate (NO3
), and total nitrates
(NO2
 þNO3). The Griess reaction method includes reduction of nitrate to ni-
trite with nitrate reductase and colorimetric determination of the diazonium
ion. Interleukin-6 (IL-6) and transforming growth factor-beta (TGF-beta)
were measured in joint ﬂuid samples using commercially available colorimet-
ric ELISA for human IL-6 and TGF-beta (Quantikine Immunoassay, R&D
Systems, Minneapolis, MN).STATISTICSLinear regression modeling using EC-SOD protein, the low molecular
weight antioxidants or other joint ﬂuid constituents as the outcome variable
wasused to test for effects of age, gender, andBMI on the relationship between
disease status and measured variable. All reported values are mean S.E.M.ResultsTHE STUDY GROUPSWe compared OA subjects with severe OA of the knee
joint to subjects who were undergoing arthroscopy for
chronic knee pain, meniscal tears and ACL reconstruction.
The OA patients were signiﬁcantly older and more obese.
The baseline characteristics and results of the two groups
are shown in Table I.EC-SOD IN JOINT FLUIDEC-SOD was found in human joint ﬂuid samples. EC-SOD
mean concentration in the joint ﬂuid was 7.3 0.9 pg/mg
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OA subjects. However there were marked differences be-
tween the two groups, with the comparison group mean
EC-SOD protein of 11.3 1.9 pg/mg total protein and the
OA group mean 5.6 pg 0.8/mg total protein (Fig. 1).
Because there were differences between the two groups
in terms of age, gender and BMI, we ﬁt a general linear
univariate model with EC-SOD protein concentration as
the outcome variable, and group (comparison or OA),
age, gender, BMI and their interactions as predictors. Using
a planned, backwards, stepwise testing procedure; gender,
BMI and their interactions were eliminated from the model.
In the ﬁnal model, group (OA vs comparison) was a very
strong predictor of EC-SOD levels (F¼ 20.3, P¼ 0.0001),
with age remaining as a less signiﬁcant predictor (F¼ 9.3,
P¼ 0.0045) and the interaction between age and group
(disease state) non-signiﬁcant in the model.LOW MOLECULAR WEIGHT ANTIOXIDANTSAscorbate was decreased in the OA joint ﬂuid at
6.2 1.9 mg/ml compared to the comparison joint ﬂuid at
13.2 2.9 mg/ml (t¼ 4.06, P¼ 0.05). Reduced GSH and
GSSG show signiﬁcant differences between the OA and
comparison joint ﬂuids (GSH, t¼ 2.9, P¼ 0.006; GSSG,
t¼ 2.95, P¼ 0.005). However, linear regression modeling
of reduced GSH demonstrates only an age effect between
the two groups with disease state, gender and BMI elimi-
nated from the model (F¼ 9.4, P¼ 0.004). GSSG is also
signiﬁcantly different between the two groups, but regres-
sion modeling (R2¼ 0.498, F¼ 4.25, P¼ 0.002) demon-
strates signiﬁcant effects from disease state, age, BMIFig. 1. EC-SOD in human joint ﬂuid. EC-SOD protein is very signif-
icantly decreased in joint ﬂuid from osteoarthritic knee joints com-
pared to subjects with mechanical symptoms or injury but with
intact cartilage (controls¼ 10.8 1.5 pg EC-SOD per mg protein,
OA ﬂuid ¼ 5.6  0.9 pg EC-SOD per mg protein, *F ¼ 15.8,
P¼ 0.004). EC-SOD as a catalytic scavenger has rate constant
of 109 and is the most rapid and effective scavenger of superoxide
in the extracellular spaces and ﬂuids. This striking deﬁciency of an-
tioxidant capacity could be a primary event due to failure of synthe-
sis in either cartilage or synovium, or could be due to excessive
degradation of the protein. If joints were stressed oxidatively by
weight-bearing activity or by the unique degradative processes in
OA, increased oxidant scavenging capacity would be an expected
homeostatic response. The observed difference in joint ﬂuid
EC-SOD may aggravate the oxidative stress within the OA joint.and their interactions. Urate was not signiﬁcantly different
between the two groups (Fig. 2).CYTOKINESTwo cytokines were measured in the joint ﬂuid as refer-
ence points. The ﬁrst was IL-6, which is one of the pro-
inﬂammatory cytokines that is most abundant in both RA
and OA. The other cytokine was the growth factor TGF-
beta, which has been strongly associated with reparative
processes and formation of osteophytes in OA. There was
a small trend to higher TGF-beta in the OA joint ﬂuids but
no signiﬁcant difference between groups. IL-6 also trended
higher in the OA joint ﬂuids compared to the comparison
samples but was not signiﬁcant. We looked at the relation-
ship in joint ﬂuid between IL-6 levels and EC-SOD protein to
assess whether joints with higher levels of IL-6 showed
a pattern of response in EC-SOD levels. There was no cor-
relation between EC-SOD levels and IL-6 for the whole
sample (r¼0.15, P¼ 0.433), or for the two groups (OA:
r¼0.13, P¼ 0.59, comparison group: r¼ 0.55, P¼ 0.19)
(Table II).NITRATES/NITRITESTotal nitrates/nitrites were measured using the Greiss re-
action and were not signiﬁcantly different in the OA joint
ﬂuid compared to the control ﬂuid. The mean values for
control samples compared to OA trended to increases in
the arthritis patients as expected, but failed to reach signif-
icance (Fig. 3). These ﬁndings and the results for TGF-beta
and IL-6 may represent the difﬁculties in deﬁning control
and disease groups well in arthritis studies due to the
late onset of the disease and extensive range of possible
etiologies in the ﬁnal pathway of OA all of which produce
a non-discrimination bias in samples (Table III).Discussion
Generation of superoxide and other more reactive
oxygen species has been demonstrated in cartilage in
response to both inﬂammatory cytokines and injurious me-
chanical forces5,16,17. Increases in the pro-inﬂammatory cy-
tokines are found in OA and there is an evidence that
reactive oxygen species play a role in the matrix dysregula-
tion of OA18. The primary scavenger of superoxide is SOD
which catalyzes the dismutation of superoxide to hydrogen
peroxide and oxygen. Local SOD deﬁciency allows super-
oxide to react with nitric oxide forming peroxynitrite and
other oxidizing species. Adequate SOD can scavenge
superoxide and permit nitric oxide to remain active as a sig-
naling molecule19,20. In scavenging superoxide, the net ef-
fect of SOD is to decrease the number of oxidizing
species and produce a reduced local redox state.
We have previously found EC-SOD to be markedly de-
creased in OA cartilage3 and now ﬁnd a signiﬁcant decrease
in the levels of EC-SOD protein in OA joint ﬂuid compared to
joints with injuries but intact cartilage. EC-SOD is an impor-
tant scavenger of superoxide in the extracellular spaces and
ﬂuids. Marklund et al.11 found SOD activity to be present in
human joint ﬂuids at concentrations three-fold higher than
plasma suggesting that it is secreted into joint ﬂuid; how-
ever, he did not look at joint ﬂuid from OA subjects. In this
study, we found that EC-SOD protein was 50% lower in se-
vere OA joint ﬂuid compared to ﬂuid from injured and painful
joints with intact cartilage. We expected to ﬁnd increased
Fig. 2. Low molecular weight antioxidants in joint ﬂuid. (A) Ascorbate showed greater than a 50% difference between the OA joint ﬂuid com-
pared to that from injured knees with macroscopically intact cartilage at arthroscopy (t¼ 2.01, P¼ 0.05). (B) Urate does not show a signiﬁcant
difference (t¼0.74, P¼ 0.45) between groups. (C) Reduced GSH is signiﬁcantly different between the two groups but linear regression
modeling demonstrates only an age effect between the two groups with disease state and interactions eliminated from the model (F¼ 9.4,
P¼ 0.004). (D) GSSG is also signiﬁcantly different between the two groups but regression modeling (R2¼ 0.498, F¼ 4.25, P¼ 0.002)
demonstrates signiﬁcant effects in the model from disease state, age, BMI and their interactions.
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oxidative stress in OA cartilage. Studies of other tissues
have shown that EC-SOD is induced in response to inﬂam-
matory cytokines and acute inﬂammation but not clearly up-
regulated in response to oxidants21e23. OA, with a chronic
inﬂammatory state, appears to lack an adaptive response
to oxidative stress within the joint. This lack of response to
oxidative stress of the major extracellular antioxidant,
EC-SOD, in OA joint ﬂuid suggests a failure of antioxidant
defenses in late stage OA.
Antioxidants represent a broad range of molecules and
enzymes that organisms have evolved to scavenge reactive
oxygen and nitrogen species. In addition to the SODs, they
include: catalase, the redox couple of GSSG and reduced
GSH, a redox couple of reduced and oxidized cysteine, per-
oxidases and several small non-enzymatic molecules such
as ascorbate, urate and the lipid soluble a-tocopherol or
vitamin E. These scavenging systems are used to prevent
oxidative damage to protein, DNA and lipids in cells and
tissues. In addition to bulk antioxidant effects, antioxidantsTable II
Cytokines in joint fluid
IL-6 (pg/ml) TGF-beta (ng/ml)
Control 85.0 150 1.97 0.53
OA 299.3 88.8 2.32 0.32
Non-signiﬁcant Non-signiﬁcantreduce thiol groups and modify redox sensitive signaling
pathways including NF-kB24,25.
Other authors have noted changes in joint ﬂuid antioxi-
dant scavenging in relationship to joint disease. Sumii
et al.26 measured total SOD activity by electron spin reso-
nance (ESR) in the joint ﬂuid of both OA (mean¼ 7.03
SOD units/ml) and RA (mean¼ 6.9 SOD units/ml) patients
but did not ﬁnd statistically signiﬁcant differences between
them. Igari et al.27 found increased total SOD activity in
the joint ﬂuid of RA patients (mean¼ 0.46 SOD units/mg
protein) compared to OA patients (mean¼ 0.12 SOD
units/mg protein) but did not study controls. Marklund found
decreased EC-SOD in the joint ﬂuid of RA (mean¼ 53.9
SOD units/mg) patients relative to controls (67.3 SOD
units/mg) but did not look at patients with OA11. He also
found that the total SOD activity was similar in controls
and RA joint ﬂuids due to the impact of SOD1 being dispro-
portionately increased in the RA subjects.
Ostalowska et al.28 recently published a study showing
higher total SOD activity in joint ﬂuid from subjects with
knee OA (mean approximately¼ 14 nitric units e NU/ml)
compared to ‘‘controls’’ with joint effusions (mean approx-
imately¼ 7 NU/ml) recruited from a rheumatology clinic.
Measurements of SOD activity vary greatly depending on
the method used as seen in the papers cited above and
this is a technically demanding assay especially when the
enzymes are in low concentration such as is commonly
found in the extracellular ﬂuids. Ostalowska et al. postulated
that the increase in SOD activity was due to inﬂammation in
the OA subjects but did not separate SOD1 and 3 activities.
Fig. 3. IL-6 and TGF-beta in joint ﬂuid. IL-6 and TGF-beta do not show a statistically signiﬁcant difference between the comparison group and
OA joint ﬂuids. The mean values for injured samples compared to OA samples trend to increase in the arthritis patients as expected, but fail to
reach signiﬁcance. This may be due to the injured knees having altered cytokines and reﬂects the difﬁculties in deﬁning control and disease
groups well in arthritis studies due to the late onset of the disease and extensive range of possible etiologies in the ﬁnal pathway of OA.
519Osteoarthritis and Cartilage Vol. 16, No. 4In this paper, we chose to focus on the EC-SOD isoenzyme
because of its importance in protecting the extracellular
compartments in tissues like cartilage, and we chose to
take advantage of an ELISA that is speciﬁc for EC-SOD
protein levels. One concern with measuring total SOD activ-
ity or CuZn activity in OA is that the measurement may be
dominated by SOD1 activity and not reﬂect activity in the
speciﬁc extracellular compartments where EC-SOD has
unique binding afﬁnity. Separating EC-SOD activity from to-
tal SOD activity is difﬁcult to accomplish accurately and is
highly variable depending on the method used.
Lunec and Blake29 measured ascorbate in serum and sy-
novial ﬂuid of RA patients and found RA serum ascorbate
(5.1 5.0 mM) to be lower than joint ﬂuid (7.8 7.9 mM).
They demonstrated that this was the result of the ascorbate
being oxidatively consumed by showing that 80% of the to-
tal ascorbate was in the oxidized form e dehydroascorbate
in both serum and joint ﬂuid. Our measurements of the re-
duced form of ascorbate were similar with OA joint ﬂuids
showing a mean of 6.2 1.9 mM.
Control of the redox state within the joint involves a bal-
ance between the generation of oxidants and having ade-
quate scavengers available. Excessive generation of
oxidants will cause the low molecular weight antioxidants
to be consumed if the catalytic defenses are not able to con-
trol the ﬂux of oxidants. Most studies of antioxidants in rela-
tion to joint disease or normal homeostasis have focused on
the intracellular SODs (CuZn SOD or Mn SOD) or on low
molecular weight non-catalytic antioxidants such as GSH,
ascorbate or urate12,30e38. In addition to these antioxidants
other authors have identiﬁed metal cofactors in joint ﬂuid
and plasma such as selenium, copper, zinc and iron that
may affect the redox state of joint ﬂuid or cartilage35,39,40.
Systemic iron and copper overload are associated withTable III
Joint fluid nitrate/nitrites
Nitrite (NO2) (mM) Nitrate (NO3) (mM) Total N (mM)
Control 33.0 4.4 35.3 8.9 68.3 11.5
OA 24.3 3.0 25.9 6.0 50.1 7.8
Non-signiﬁcant Non-signiﬁcant Non-signiﬁcantincreased risk of arthritis while selenium deﬁciency is asso-
ciated with arthritis. Iron and copper may drive the redox
state toward oxidation by the Fenton reaction, which gener-
ates hydroxyl radicals, while selenium is part of the active
center of GSH peroxidase. Thus storage proteins that
bind metals (ferritin, ceruloplasm, and transferrin) may
also act as antioxidants. Low molecular weight antioxidants
are consumed in redox reactions while catalytic antioxi-
dants remain active and function at high rate constants in
scavenging oxidants. These properties of catalytic antioxi-
dants make them signiﬁcantly more efﬁcient than the low
molecular weight antioxidants.
Ascorbate is a low molecular weight antioxidant that can
act both as a reductant or an oxidant depending on the re-
dox state of the system. In a surgical animal model of OA,
ascorbate protected cartilage, but in a spontaneous guinea
pig model, increased ascorbate worsened the progres-
sion41,42. An acute inﬂammation model showed that ascor-
bate did not protect lipids and amino acids from oxidation43.
Our ﬁnding that ascorbate is decreased in OA joint ﬂuid, we
believe, is the result of consumption by oxidation reactions.
We did not assess the subjects’ oral intakes of ascorbate or
measure their serum ascorbate levels and those may be
confounders in these results.
Reduced GSH showed signiﬁcant differences between
the two groups and in a regression model this was largely
the result of age differences between the groups. GSH
levels in blood have been shown to generally decrease
with age, but high levels of plasma GSH predict fewer dis-
eases and better health in aging44,45. Reduced GSH and
GSSG have not been measured previously in osteoarthritic
joint ﬂuid.
The decreases in EC-SOD and ascorbate in OA joint
ﬂuid suggest that there has not been an effective up-
regulation of antioxidant protection in the OA joint to the
state of oxidative stress that we found in cartilage tissue.
The antioxidant deﬁciency seen in cartilage tissue is com-
pounded by further deﬁcits in the joint ﬂuid. This may be
a failure of adaptation and response in OA, or a primary
feature of the disease. EC-SOD is the major catalytic scav-
enger of superoxide in the joint ﬂuid and with its high rate
constant, it is much more effective than other antioxidants
in controlling the redox state. It is interesting, but not
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in joint ﬂuid also have failed to compensate for the lack of
EC-SOD in OA joint ﬂuid. Our ﬁnding in late stage OA that
urate is only increased slightly and ascorbate and GSH
were both decreased suggests a broad dysregulation
and/or depletion of antioxidant scavenging in association
with OA.
The selection of controls for this type of study is chal-
lenging because in the completely normal knee joint it is
difﬁcult to collect joint ﬂuid. Although the normal joint
can be lavaged to sample the constituents of the joint
ﬂuid, this introduces dilutional errors. In our control pa-
tients, meniscal tears, chronic joint instability and unre-
solved knee pain were the underlying conditions that
prompted arthroscopy. None of the subjects had acute
knee injuries or hemarthrosis; all of the subjects were having
elective knee arthroscopy after trials of conservative man-
agement. Findings at arthroscopy included: no abnormal-
ity, meniscal tear, subacute or chronic ACL tear, and
small, superﬁcial chondral lesions. Each of these diagno-
ses is a risk factor for OA and may potentially alter the
levels of antioxidants in the joint. In spite of these potential
confounders that would tend to decrease our ability to dis-
cern a difference between groups, EC-SOD, ascorbate
and GSH/GSSG were signiﬁcantly different between the
two groups. These results suggest that a change occurred
in the joint’s balance of oxidants and antioxidants in asso-
ciation with OA and that the alterations occurred between
the point where joints are ‘‘at risk’’ and the development of
advanced OA.
In our relatively small sample size we did not identify any
signiﬁcant differences in nitrites/nitrates, IL-6 or TGF-beta,
although each of them trended to increases in the OA group
as other researchers have found46e48. We postulate that
our sample size did not have adequate power to detect
these differences. There may be unknown confounding fac-
tors between the two groups that were not matched for age,
BMI or gender. Our regression modeling technique sug-
gests that for EC-SOD there are no interactions between
disease state and the other factors of age and BMI. How-
ever, repeating this study with matched controls or in a pro-
spective cohort would provide important validation of the
results. It would be valuable to assess joint ﬂuid from OA
subjects in the early and mid-stages of disease to see if
EC-SOD levels directly vary with disease severity and
whether EC-SOD may be able to function as a biomarker
for joints at risk of or with OA.
This joint ﬂuid study supports the hypothesis that there is
oxidant stress associated with late stage human OA by
demonstrating decreases in key antioxidants. In addition
to EC-SOD deﬁciency in cartilage tissue we now show
that the joint ﬂuid has also failed to compensate for the
lack of oxidant scavenging in the cartilage and it is also de-
ﬁcient in EC-SOD. Age related decreases in ascorbate and
GSH scavenging aggravate the losses of EC-SOD in the
osteoarthritic cartilage and joint ﬂuid and lead to a higher
oxidation state. We postulate that the effect of inadequate
oxidant scavenging in the joint is both activation of metallo-
proteinases and direct oxidant damage to the structural
extracellular matrix proteins in cartilage, as well as depoly-
merization of hyaluronate in joint ﬂuid leading to changes in
joint ﬂuid viscosity. We further believe that inadequate oxi-
dant scavenging leads to increased formation of reactive
nitrogen species from excess superoxide reacting with nitric
oxide within the joint as demonstrated in other studies. All of
these effects result in the cartilage matrix dysregulation and
tissue loss associated with OA.Acknowledgements
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